What progesterone dose and dosing schedule should be used for a woman with an intact uterus who is treating vaginal atrophy with estradiol vaginal cream applied three times weekly?

Progesterone Dosing for Endometrial Protection with Low-Dose Vaginal Estrogen

For a woman with an intact uterus using estradiol vaginal cream 3 times weekly for vaginal atrophy, you do NOT need to add systemic progesterone for endometrial protection. Low-dose vaginal estrogen preparations used for local treatment of vaginal atrophy have minimal systemic absorption and do not require routine progestogen opposition 1, 2.

Key Clinical Decision Point: Dose Matters

The critical distinction is whether the vaginal estrogen is truly "low-dose":

Low-dose vaginal estrogen preparations include:

• Estradiol vaginal tablets 10 µg
• Estradiol vaginal ring (releasing 7.5 µg/day)
• Low-dose estradiol cream (typically 0.5 g containing ~0.5 mg estradiol or less)

These preparations result in minimal systemic absorption, with estradiol levels remaining within the normal postmenopausal range 2.

If using intermediate or high-dose vaginal estrogen (such as conjugated estrogen cream 0.625-2.5 mg daily or estradiol cream 2-4 g daily), systemic absorption occurs and endometrial protection becomes necessary 1.

When Progesterone IS Required

If systemic estrogen absorption is occurring (evidenced by relief of systemic menopausal symptoms, not just local vaginal symptoms), add progesterone using one of these evidence-based regimens 1:

Sequential (Cyclic) Regimens - First Choice:

• Micronized progesterone: 200 mg orally for 12-14 days per month 1, 3, 4
• Medroxyprogesterone acetate: 5-10 mg orally for 10-12 days per month 1
• Norethindrone acetate: 5 mg orally for 10-12 days per month 1

Continuous Combined Regimens (if avoiding withdrawal bleeding):

• Micronized progesterone: 100 mg orally daily 1
• Medroxyprogesterone acetate: 2.5 mg orally daily 1
• Norethindrone acetate: 0.35 mg orally daily 1

Micronized progesterone is preferred as the first-line progestogen due to its physiological profile and lower cardiovascular risk compared to synthetic progestogens 3.

Important Caveats

Monitor for systemic absorption: Vaginal estrogen can have systemic effects depending on dose and formulation 1. If the patient develops relief of systemic menopausal symptoms (hot flashes, night sweats) while using "vaginal-only" estrogen, this indicates systemic absorption and necessitates adding progesterone.

Abnormal bleeding requires evaluation: Any unexpected vaginal bleeding during treatment requires endometrial assessment with ultrasound and/or biopsy, regardless of the regimen used 1.

Alternative vaginal progesterone: While transvaginal micronized progesterone (100-200 mg for 12-14 days per month) has been studied and shows endometrial protection 5, 6, 7, it is not FDA-approved for this indication and has Grade C evidence 1. However, it may be considered for women who cannot tolerate oral progestogens.

Practical Algorithm

1. Confirm the vaginal estrogen dose - Check if truly low-dose preparation
2. Assess for systemic symptoms - Are hot flashes/night sweats improving?
3. If NO systemic absorption → No progesterone needed
4. If YES systemic absorption → Add micronized progesterone 200 mg orally for 12-14 days per month
5. Monitor bleeding patterns - Investigate any unexpected bleeding

The FDA label for oral progesterone specifically states 200 mg daily for 12 days per 28-day cycle when combined with conjugated estrogens 0.625 mg in postmenopausal women with intact uterus 4.